Experience with efavirenz in end-stage renal disease

Int J STD AIDS. 2003 Jul;14(7):497-8. doi: 10.1258/095646203322025830.

Abstract

There are few data on the use of highly active antiretroviral therapy in HIV-positive patients with end-stage renal disease. We describe the tolerability, safety and efficacy of an efavirenz-containing regimen in one such patient on continuous ambulatory peritoneal dialysis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Alkynes
  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active
  • Benzoxazines
  • Cyclopropanes
  • Female
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Humans
  • Kidney Failure, Chronic / etiology
  • Kidney Failure, Chronic / therapy*
  • Oxazines / therapeutic use*
  • Peritoneal Dialysis, Continuous Ambulatory*

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • Oxazines
  • efavirenz